David L Kemmerly, Amedisys Inc's See Remarks, recently cashed-in 6,000 options. The options were exercised at $27.35, while the disposals took place between $78.69 and $79.86 per share, on June 07, 2018. Kemmerly continues to hold 18,377 shares of the company. Kemmerly operates out of Baton Rouge, LA. Some additional info was provided as follows:
The total amount of shares beneficially owned includes 176 shares held in an employee stock purchase plan account.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.40 to $79.36, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchan
ge Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.43 to $80.30, inclusive.
The information in this report is based on a plan statement dated as of March 31, 2018.
On May 1, 2015, the reporting person was granted an option to purchase 37,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2015 were met, resulting in vesting of the option as to 9,375 shares (the "2015 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2015 Tranche Options vested on May 1, 2016, one-third of the 2015 Tranche Options vested on May 1, 2017 and one-third of the 2015 Tranche Options vested on May 1, 2018.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Amedisys Inc makes a similar move, sign up!
Other recent filings from the company include the following:
Amedisys: Compassionate Care Hospice Group, Inc AND SUBSIDIARIES AND AFFILIATES - April 17, 2019
Amedisys: Vice President Of Marketing & Communications - April 1, 2019